Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study

Herbal Preparation ◽

Double Blind

Faculty Opinions recommendation of Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026783.793483711 ◽

2013 ◽

Author(s):

Ivano Biviano

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Herbal Preparation ◽

Double Blind

Faculty of 1000 evaluation for Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718026783.793485785 ◽

2013 ◽

Author(s):

Kellie Mathis

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Herbal Preparation ◽

Double Blind

Faculty Opinions recommendation of Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7569957.7866056 ◽

2011 ◽

Author(s):

Russell Cohen ◽

Laura Harrell

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Sustained Release ◽

Herbal Extract ◽

Double Blind ◽

Blind Comparison

Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2021.111580 ◽

2021 ◽

Vol 139 ◽

pp. 111580

Author(s):

Hong Shen ◽

Shengsheng Zhang ◽

Wenxia Zhao ◽

Shunping Ren ◽

Xiao Ke ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Clinical Trial

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04515.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 194-202 ◽

Cited By ~ 57

Author(s):

T. Tang ◽

S. R. Targan ◽

Z.-S. Li ◽

C. Xu ◽

V. S. Byers ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Sustained Release ◽

Herbal Extract ◽

Double Blind ◽

Blind Comparison

Randomised clinical trial: early assessment after 2weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Yearbook of Medicine ◽

10.1016/s0084-3873(11)00325-7 ◽

2011 ◽

Vol 2011 ◽

pp. 450-451

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

High Dose ◽

Early Assessment

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Faculty Opinions recommendation of Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718077478.793485219 ◽

2013 ◽

Author(s):

Ivano Biviano

Keyword(s):

Clinical Trial ◽

Diverticular Disease ◽

Uncomplicated Diverticular Disease

Controlled Study ◽

Double Blind ◽

Reply to Drs Munkholm and Paludan-Müller’s comment on our paper “Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial”

Neuropsychopharmacology ◽

10.1038/s41386-021-01042-1 ◽

2021 ◽

Author(s):

Maria A. Nettis ◽

Carmine M. Pariante ◽

Valeria Mondelli

Keyword(s):

Clinical Trial ◽

Peripheral Inflammation ◽

Low Grade ◽

Treatment Resistant Depression ◽

Augmentation Therapy ◽

Treatment Resistant ◽

Double Blind ◽

Resistant Depression

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2011.04818.x ◽

2011 ◽

Vol 34 (8) ◽

pp. 868-877 ◽

Cited By ~ 27

Author(s):

J. F. Tack ◽

P. B. Miner ◽

L. Fischer ◽

M. S. Harris

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Irritable Bowel